KATHERINE TUCKER: Open Payments
NPI 1932568482 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 68 payments from 17 companies in 2025. Trend: 2023 $1,379 · 2024 $1,514 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $518 |
| Amgen Inc. | 7 | $199 |
| GlaxoSmithKline, LLC. | 17 | $172 |
| Novo Nordisk Inc | 9 | $142 |
| ABBVIE INC. | 7 | $112 |
| Lilly USA, LLC | 5 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Exact Sciences Corporation | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Antares Pharma, Inc. | 2 | $28 |
Products named: BREZTRI, TRELEGY ELLIPTA, FARXIGA, REPATHA, VRAYLAR, Kerendia, Wegovy, MOUNJARO.
Industry payments across IN — which companies pay providers there.
